
<p>The pharmacokinetics and tissue residue of toltrazuril (Baycox<sup>®</sup>, Bayer Animal Health) were investigated in broiler chickens after repeated oral administrations of 7 mg/kg b.wt once daily for two consecutive days. Chickens were subjected to clinical diagnosis to ensure that each one is free from any Eimeria was received a standard broiler feed free from any medications. The results revealed that following repeated oral administration; toltrazuril peaked in blood with [C<sub>max</sub>] of 6.56 and 6.70 μg/ml at [T<sub>max</sub>] of 2.56 and 2.52 hours and the elimination half-life [t<sub>1/2β</sub>] of 14.92 and 16.19 hours and the mean residence times (MRT) were 21.33 and 23.14 hours after first and second doses, respectively. The tissue level concentrations were highest in the kidney and decreased in the following order: liver > lung > heart > muscle > skin and fat. No toltrazuril residues were detected in tissues and plasma after 8 days.</p>
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 9 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
